Helicobacter pylori: Difference between revisions
From IDWiki
Helicobacter pylori
m (Text replacement - "[[Has oxidase test::" to "[[Oxidase test::") |
m (Text replacement - "[[Has shape::" to "[[Cellular shape::") |
||
| Line 1: | Line 1: | ||
* Slow-growing [[Has Gram stain::Gram-negative]] microaerophilic [[ |
* Slow-growing [[Has Gram stain::Gram-negative]] microaerophilic [[Cellular shape::bacillus]] with a curve, gull-wing, or spiral appearance |
||
* [[Oxidase test::Oxidase-positive]] and [[Has urease test::urease-positive]] |
* [[Oxidase test::Oxidase-positive]] and [[Has urease test::urease-positive]] |
||
* Major cause of peptic ulcer disease and gastric cancer |
* Major cause of peptic ulcer disease and gastric cancer |
||
Revision as of 20:45, 5 July 2020
- Slow-growing Gram-negative microaerophilic bacillus with a curve, gull-wing, or spiral appearance
- Oxidase-positive and urease-positive
- Major cause of peptic ulcer disease and gastric cancer
References
- ^ M. Zamani, F. Ebrahimtabar, V. Zamani, W. H. Miller, R. Alizadeh‐Navaei, J. Shokri‐Shirvani, M. H. Derakhshan. Systematic review with meta‐analysis: the worldwide prevalence of Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics. 2018;47(7):868-876. doi:10.1111/apt.14561.
- ^ G. Manes, A. Balzano, G. Iaquinto, C. Ricci, M. M. Piccirillo, N. Giardullo, A. Todisco, M. Lioniello, D. Vaira. Accuracy of the stool antigen test in the diagnosis of Helicobacter pylori infection before treatment and in patients on omeprazole therapy. Alimentary Pharmacology & Therapeutics. 2001;15(1):73-79. doi:10.1046/j.1365-2036.2001.00907.x.
